136 related articles for article (PubMed ID: 33517655)
41. Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery.
Widera A; Norouziyan F; Shen WC
Adv Drug Deliv Rev; 2003 Nov; 55(11):1439-66. PubMed ID: 14597140
[TBL] [Abstract][Full Text] [Related]
42. Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy.
Anabousi S; Laue M; Lehr CM; Bakowsky U; Ehrhardt C
Eur J Pharm Biopharm; 2005 Jul; 60(2):295-303. PubMed ID: 15939240
[TBL] [Abstract][Full Text] [Related]
43. Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers.
Widera A; Kim KJ; Crandall ED; Shen WC
Pharm Res; 2003 Aug; 20(8):1231-8. PubMed ID: 12948021
[TBL] [Abstract][Full Text] [Related]
44. Impairment of protein trafficking upon overexpression and mutation of optineurin.
Park B; Ying H; Shen X; Park JS; Qiu Y; Shyam R; Yue BY
PLoS One; 2010 Jul; 5(7):e11547. PubMed ID: 20634958
[TBL] [Abstract][Full Text] [Related]
45. Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy.
Wu H; Yao L; Mei J; Li F
Int J Clin Exp Pathol; 2015; 8(1):207-16. PubMed ID: 25755707
[TBL] [Abstract][Full Text] [Related]
46. Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery.
Singh RP; Sharma G; Sonali ; Singh S; Patne SCU; Pandey BL; Koch B; Muthu MS
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():313-325. PubMed ID: 27287127
[TBL] [Abstract][Full Text] [Related]
47. Transferrin receptor 2 mediates a biphasic pattern of transferrin uptake associated with ligand delivery to multivesicular bodies.
Robb AD; Ericsson M; Wessling-Resnick M
Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1769-75. PubMed ID: 15317665
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of improved PAMAM-G5 conjugates for gene delivery targeted to the transferrin receptor.
Urbiola K; Blanco-Fernández L; Navarro G; Rödl W; Wagner E; Ogris M; Tros de Ilarduya C
Eur J Pharm Biopharm; 2015 Aug; 94():116-22. PubMed ID: 26004821
[TBL] [Abstract][Full Text] [Related]
49. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
[TBL] [Abstract][Full Text] [Related]
50. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
51. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
52. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
Muddineti OS; Kumari P; Ghosh B; Biswas S
Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
[TBL] [Abstract][Full Text] [Related]
53. Human MRCKalpha is regulated by cellular iron levels and interferes with transferrin iron uptake.
Cmejla R; Ptackova P; Petrak J; Savvulidi F; Cerny J; Sebesta O; Vyoral D
Biochem Biophys Res Commun; 2010 Apr; 395(2):163-7. PubMed ID: 20188707
[TBL] [Abstract][Full Text] [Related]
54. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y
Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775
[TBL] [Abstract][Full Text] [Related]
55. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
[TBL] [Abstract][Full Text] [Related]
56. Transferrin-conjugated pH-sensitive platform for effective delivery of porous palladium nanoparticles and paclitaxel in cancer treatment.
Nguyen HT; Soe ZC; Yang KY; Phung CD; Nguyen LT; Jeong JH; Jin SG; Choi HG; Ku SK; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2019 Apr; 176():265-275. PubMed ID: 30623814
[TBL] [Abstract][Full Text] [Related]
57. Spatiotemporal Tracing of the Cellular Internalization Process of Rod-Shaped Nanostructures.
Wang YF; Zhang Q; Tian F; Wang H; Wang Y; Ma X; Huang Q; Cai M; Ji Y; Wu X; Gan Y; Yan Y; Dawson KA; Guo S; Zhang J; Shi X; Shan Y; Liang XJ
ACS Nano; 2022 Mar; 16(3):4059-4071. PubMed ID: 35191668
[TBL] [Abstract][Full Text] [Related]
58. Oligomerized transferrin receptors are selectively retained by a lumenal sorting signal in a long-lived endocytic recycling compartment.
Marsh EW; Leopold PL; Jones NL; Maxfield FR
J Cell Biol; 1995 Jun; 129(6):1509-22. PubMed ID: 7790351
[TBL] [Abstract][Full Text] [Related]
59. Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy.
Ikuta K; Yersin A; Ikai A; Aisen P; Kohgo Y
J Mol Biol; 2010 Mar; 397(2):375-84. PubMed ID: 20096706
[TBL] [Abstract][Full Text] [Related]
60. Targeting of the photocytotoxic compound AlPcS4 to Hela cells by transferrin conjugated PEG-liposomes.
Gijsens A; Derycke A; Missiaen L; De Vos D; Huwyler J; Eberle A; de Witte P
Int J Cancer; 2002 Sep; 101(1):78-85. PubMed ID: 12209592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
